HNA Technology Investments : Appointment of Independent Non-executive Director and Changes to Composition of Board Committees

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

HNA Technology Investments Holdings Limited ऎঘ߅Ҧҳ༟છٰϞࠢʮ̡

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 2086)

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

AND

CHANGES TO COMPOSITION OF BOARD COMMITTEES

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

The Board announces that Dr. Lin has been appointed as an independent non-executive Director and the chairman of the Audit Committee with effect from 22 December 2017.

CHANGES TO COMPOSITION OF BOARD COMMITTEES

The Board further announces that Mr. Peng Fang is appointed as a member of the Remuneration Committee in place of Mr. Wong Chi Ho with effect from 22 December 2017.

COMPLIANCE WITH RULES 3.10, 3.10A AND 3.21 OF THE LISTING RULES

Following the appointment of Dr. Lin as set out above, the Company comprises five executive Directors and three independent non-executive Directors. As a result, the Company has complied with (i) Rules 3.10 and 3.10A of the Listing Rules in relation to the composition of the Board and (ii) Rule 3.21 of the Listing Rules with regard to the composition of the Audit Committee.

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

The board (the "Board") of directors (the "Directors") of HNA Technology Investments Holdings Limited (the "Company") is pleased to announce that with effect from 22 December 2017, Dr. Lin Tat Pang (ஹ༺ᘄ) ("Dr. Lin") is appointed as an independent non-executive Director and the chairman of the audit committee of the Company (the "Audit Committee").

The biographical details and other information of Dr. Lin is set out below:

Dr. Lin Tat Pang (ஹ༺ᘄ), aged 61, is an independent non-executive Director and the chairman of the Audit Committee.

Dr. Lin is also an independent non-executive director of China Aluminum Cans Holdings Limited (Main Board listed company with stock code: 06898) since June 2013.

Dr. Lin has over 30 years of experience in accounting, finance and public offerings. Dr. Lin served as assistant accountant, accounting manager and chief accountant in Sun Hung Kai Securities Limited during 1980 to 1988. He joined Sun Hung Kai Investment Services Limited and Sun Hung Kai Forex & Bullion Co. Limited as executive director in December 1989. He was also appointed as company secretary of Sun Hung Kai & Co. Limited (Main Board listed company with stock code: 00086) in November 1990. Subsequently, he worked for Hong Kong Exchanges and Clearing Limited and the Stock Exchange between December 1992 and March 2013, and his last position was senior consultant to the Listing, Listing & Regulatory Affairs Division of Hong Kong Exchanges and Clearing Limited.

Dr. Lin obtained his Doctor of Law, Master of Law and Bachelor of Law from Peking University* (̏ԯɽኪ) in 2009, 1998 and 1992 respectively. He also completed his Postgraduate Certificate in Hong Kong Law in City University of Hong Kong (previously known as City Polytechnic of Hong Kong) in 1993. Dr. Lin is a member of the Hong Kong Institute of Certified Public Accountants and a fellow of the Chartered Association of Certified Accountants, United Kingdom. He is also a member of the Chartered Institute of Arbitrators, United Kingdom.

Dr. Lin has entered into a letter of appointment with the Company pursuant to which he has agreed to act as an independent non-executive Director for a term of two years commencing from 22 December 2017 unless terminated by three month's written notice or in certain circumstances as in accordance with the terms of the letter of appointment. Pursuant to the letter of appointment, Dr. Lin will receive a basic remuneration of HK$240,000 per annum, which is determined with reference to the remuneration policy of the Company, his duties and responsibilities with the Company and the prevailing market conditions, and such other benefits as may be determined by, and at the discretion of, the Board from time to time.

As at the date of this announcement, save as disclosed above, Dr. Lin (i) does not have any relationship with any directors, senior management or substantial or controlling shareholders of the Company; (ii) does not have any interests in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance; (iii) does not hold any other positions with any members of the Group and (iv) does not have any directorship in other listed public companies in the past three years.

Saved as disclosed above, there is no other information to be disclosed pursuant to paragraphs (h) to (v) of Rule 13.51(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and there are no other matters that need to be brought to the attention of the shareholders of the Company in connection with Dr. Lin's appointment.

CHANGES TO COMPOSITION OF BOARD COMMITTEES

The Board further announces that with effect from 22 December 2017, Mr. Peng Fang is appointed as a member of the remuneration committee of the Company (the "Remuneration Committee") in place of Mr. Wong Chi Ho.

Upon the above changes taking effect, the composition of the Audit Committee and the Remuneration Committee are as follows:

Audit Committee

Dr. Lin Tat Pang (Chairman) Mr. Guo Dan

Ms. Kaung Cheng Xi Dawn

Remuneration Committee

Ms. Kaung Cheng Xi Dawn (Chairman) Mr. Guo Dan

Mr. Peng Fang

COMPLIANCE WITH RULES 3.10, 3.10A AND 3.21 OF THE LISTING RULES

Following the appointment of Dr. Lin as set out above, the Company comprises five executive Directors and three independent non-executive Directors. As a result, the Company has complied with (i) Rules 3.10 and 3.10A of the Listing Rules in relation to the composition of the Board and (ii) Rule 3.21 of the Listing Rules with regard to the composition of the Audit Committee.

The Board would like to take this opportunity to welcome Dr. Lin to the new position.

By order of the Board

HNA Technology Investments Holdings Limited

TONG Fu

Chairman

Hong Kong, 22 December 2017

As at the date of this announcement, the Board comprises five executive Directors, namely, Mr. Tong Fu, Mr. Wang Hao, Mr. Peng Fang, Mr. Zhang Tao and Mr. Wong Chi Ho; and three independent non-executive Directors, Mr. Guo Dan, Ms. Kaung Cheng Xi Dawn and Dr. Lin Tat Pang.

*

For identification purposes only